MENU
Revance Therapeutics (RVNC) Ownership - Who owns Revance Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
685.51M
P/E Ratio
N/A
Total Cash
232.24M
Projected Growth
N/A
Total Debt
491.64M
Revenue
251.18M
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
2.23
Total Debt/Equity
N/A
Revenue/Share
2.72 USD as % of share price
Fundamentals
RVNC
Capitalization
686M
P/E Ratio
N/A
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash
232M
Total Cash/Share
2.23
Total Debt
492M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.72%
Revenue
251M
ROE
N/A
Book Value
-129.74M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-3.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
105K
Current Ratio
3.74
Current Revenue Per Employee
109529.31
Dividends Per Share - Security
N/A
EBITDA
-274.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
73.03
Revenue To Assets
-52.70
Shares Held By Institutions
450M
Shares Outstanding - Current
104M
Total Liabilities
625M
Total Volume MTD
N/A
Value
-1
Gain YTD
-25.256
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com